Table 2

Comparison of patients’ data between SAH and VHM groups

SAHVHMTotalP value
Patients, n103 (52.0)90 (45.5)193
Lesions, n113 (54.3)90 (43.3)203
Male sex82 (79.6)79 (87.8)161 (83.4)0.184
Median age (IQR)52 (46–60)59 (51–65)56 (47–63) <0.001
Pretreatment mRS0.150
 127 (26.2)24 (26.7)51 (26.4)
 241 (39.8)22 (24.4)63 (32.6)
 313 (12.6)11 (12.2)24 (12.4)
 47 (6.8)15 (16.7)22 (11.4)
 515 (14.6)18 (20.0)33 (17.1)
AVF type <0.001
 PMAVF1 (0.9)1 (1.1)2 (1.0)1.000
 Epidural AVF14 (12.4)4 (4.4)18 (8.9) 0.048
 Paravertebral AVF13 (11.5)2 (2.2)15 (7.4) 0.012
 Radicular AVF29 (25.7)10 (11.1)39 (19.2) 0.009
 Dural AVF56 (49.6)73 (81.1)129 (63.5) <0.001
 Side0.422
 Left50 (44.2)43 (47.8)93 (45.8)
 Right61 (54.0)43 (47.8)104 (51.2)
 Both2 (1.8)4 (4.2)6 (3.0)
Fistula location 0.007
 Foramen magnum6 (5.3)15 (16.7)21 (10.3) 0.008
 C-178 (69.0)63 (70.0)141 (69.5)0.881
 C-229 (25.7)12 (13.3)41 (20.2) 0.030
Arterial feeders <0.001
 Dural branch of vertebral artery64 (62.1)70 (77.8)134 (66.0) 0.019
 Radicular artery28 (27.2)10 (11.1)38 (18.7) 0.005
 Anterior spinal artery27 (26.2)5 (5.6)32 (15.8) <0.001
 Lateral spinal artery16 (15.5)4 (4.4)20 (9.9) 0.012
 Posterior inferior cerebellar artery3 (2.9)2 (2.2)5 (2.5)1.000
 Ascending pharyngeal artery6 (5.8)14 (15.6)20 (9.9) 0.027
Occipital artery2 (1.9)6 (6.7)8 (3.9)0.200
Posterior meningeal artery4 (3.9)1 (1.1)5 (2.5)0.450
 Middle meningeal artery0 (0.0)1 (1.1)1 (0.5)0.466
Direction of the venous drainage <0.001
 Ascending intradural69 (61.1)6 (6.7)75 (36.9) <0.001
 Descending intradural14 (12.4)70 (77.8)84 (41.4) <0.001
 Bidirectional intradural14 (12.4)10 (11.1)24 (11.8)0.779
 Epidural16 (14.2)2 (2.2)18 (8.9) 0.003
 Paravertebral venous plexus0 (0.0)2 (2.2)2 (1.0)0.195
Aneurysmal structure47 (45.6)13 (14.4)60 (29.6) <0.001
Varix66 (64.1)66 (73.3)132 (65.0)0.168
Treatment0.351
 Conservative3 (2.9)1 (1.1)4 (2.0)
 Surgery76 (73.8)73 (81.1)149 (73.4)
 Embolisation6 (5.8)7 (7.8)13 (6.4)
 Embolisation+surgery18 (17.5)9 (10.0)27 (13.3)
Complications20 (19.4)14 (15.6)34 (16.7)0.482
Recurrence3 (2.9)5 (4.4)8 (3.9)0.578
Post-treatment modified Rankin Scale (mRS)* <0.001
 049 (47.6)14 (15.6)63 (31.0)
 146 (44.7)30 (33.3)76 (37.4)
 21 (1.0)10 (11.1)11 (5.4)
 31 (1.0)12 (13.3)13 (6.4)
 43 (2.9)11 (12.2)14 (6.9)
 50 (0.0)5 (5.6)5 (2.5)
 63 (2.9)8 (8.9)11 (5.4)
  • Values are shown as the number (%) of patients or lesions, unless indicated otherwise.

  • *Post-treatment mRS was evaluated according to the last follow-up.

  • AVF, arteriovenous fistula; C, cervical; SAH, subarachnoid haemorrhage; VHM, venous hypertensive myelopathy.